PAR 5.77% 24.5¢ paradigm biopharmaceuticals limited..

WTF- what's with the share price movement, page-58

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    1) The cash position is not as bad as originally feared, won't need a cap raise at least until mid 2023.
    - We should soon hear about the R&D rebate, estimated to be approx 20 mill as suggested by others

    2) Multiple inflection point catalysts about to drop in the next two months, which include:
    - Canine and PARA 008 DMOAD top-line data read out
    - A DSMB readout for PARA 002

    IMO the SP hasn't even remotely priced in DMOAD for iPPS, which might explain the current SP action. I'm not yet sure if the current SP action is short sellers closing out their positions or funds buying in on anticipation of good DMOAD results. If the DMOAD results are good, then i expect it's going to be a buying frenzy in what is a tightly held stock.

    My views only, not advice, dyor

 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.015(5.77%)
Mkt cap ! $85.70M
Open High Low Value Volume
26.0¢ 26.0¢ 24.5¢ $265.4K 1.050M

Buyers (Bids)

No. Vol. Price($)
8 130186 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 11571 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.